![Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease - Gastroenterology Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8786c7f4-3d3c-4c98-bc61-fca2c88748a8/fx1.jpg)
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease - Gastroenterology
![Table III from The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. | Semantic Scholar Table III from The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4ec1c3abe5fca86a4d22a5305a427bcf5613e89/7-TableIII-1.png)
Table III from The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. | Semantic Scholar
![Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity - Clinical Gastroenterology and Hepatology Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/432386/3011157/gr1.jpg)
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity - Clinical Gastroenterology and Hepatology
View of A multicenter, prospective, observational study of the long-term outcomes of Crohn's disease patients under routine care management in Greece | Annals of Gastroenterology
![Galen eCalcs - Calculator: Rheumatoid Arthritis Clinical Disease Activity Index - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki Galen eCalcs - Calculator: Rheumatoid Arthritis Clinical Disease Activity Index - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki](https://wiki.galenhealthcare.com/images/thumb/9/97/CDAI2020.png/600px-CDAI2020.png)
Galen eCalcs - Calculator: Rheumatoid Arthritis Clinical Disease Activity Index - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
![The Lancet Gastroenterology & Hepatology on Twitter: "Bruce Sands presents results from the head-to-head SEAVUE randomised trial of ustekinumab vs adalimumab for induction and maintenance in moderate-to-severe #Crohns disease #DDW2021 #gitwitter #IBD The Lancet Gastroenterology & Hepatology on Twitter: "Bruce Sands presents results from the head-to-head SEAVUE randomised trial of ustekinumab vs adalimumab for induction and maintenance in moderate-to-severe #Crohns disease #DDW2021 #gitwitter #IBD](https://pbs.twimg.com/media/E2GUMKgWQAkhXiu.jpg)
The Lancet Gastroenterology & Hepatology on Twitter: "Bruce Sands presents results from the head-to-head SEAVUE randomised trial of ustekinumab vs adalimumab for induction and maintenance in moderate-to-severe #Crohns disease #DDW2021 #gitwitter #IBD
![CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice | Annals of the Rheumatic Diseases CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/5/671/F1.large.jpg)
CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice | Annals of the Rheumatic Diseases
![Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/73ac20d2-0458-4c0f-91e3-fd1c10e05b5d/gr1.jpg)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet
![A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dd5341b3-a65d-4de1-a58c-833f7fd3c469/apt13001-fig-0003-m.jpg)
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease | PLOS ONE
![PDF) CDAI (clinical disease activity index) in rheumatoid arthritis: cut-off values for classification into different grades of disease activity | rr raja - Academia.edu PDF) CDAI (clinical disease activity index) in rheumatoid arthritis: cut-off values for classification into different grades of disease activity | rr raja - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49394473/mini_magick20190131-26445-qdvup1.png?1548981966)
PDF) CDAI (clinical disease activity index) in rheumatoid arthritis: cut-off values for classification into different grades of disease activity | rr raja - Academia.edu
![A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/77ae2821-3cd6-4e8e-b9ae-21c9060def69/apt13001-fig-0001-m.jpg)
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity - Khanna - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Rheumatoid arthritis disease activity index-5: Utility in busy clinical settings Singh H, Tanwar VS, Sukhija G, Mathur R, Kaur P - Indian J Rheumatol Rheumatoid arthritis disease activity index-5: Utility in busy clinical settings Singh H, Tanwar VS, Sukhija G, Mathur R, Kaur P - Indian J Rheumatol](https://www.indianjrheumatol.com/articles/2017/12/2/images/IndianJRheumatol_2017_12_2_72_199127_t1.jpg)
Rheumatoid arthritis disease activity index-5: Utility in busy clinical settings Singh H, Tanwar VS, Sukhija G, Mathur R, Kaur P - Indian J Rheumatol
![Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease | Scientific Reports Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-96289-5/MediaObjects/41598_2021_96289_Fig3_HTML.png)